Case Report: A Woman Using Progestin Injectable Contraception for 9 Years

Iqlima Hastuti Jatmiko, Teta Puji Rahayu, Nurlailis Saadah, Rahayu Sumaningsih

Abstract


Long-term use of progestin injectable contraception may increase the risk of menstrual disorders, decreased bone mineral density, reduced libido, and reduced quality of life. This study aimed to describe the midwifery care provided to a three-month progestin injectable contraceptive acceptor who had used the method for nine years. This study employed a case report design using a midwifery management approach with SOAP (Subjective, Objective, Assessment, and Plan) documentation. The client was a 42-year-old woman who had used three-month progestin injectable contraception for nine years because she no longer wished to become pregnant. She had previously used an implant, a one-month injectable contraceptive, and a three-month injectable contraceptive. Her body weight decreased from 58 kg to 55 kg while using the implant and returned to 58 kg after switching to injectable contraception. During the use of the three-month progestin injectable contraceptive, she experienced persistent amenorrhea. After receiving comprehensive midwifery care, including assessment, education, counseling, and evaluation, the client decided to switch to an intrauterine device (IUD) on June 29, 2026.Comprehensive midwifery care, including assessment, education, counseling, and evaluation, improved the client's understanding of selecting an appropriate contraceptive method based on her health condition, age, and mutual agreement with her husband.

Full Text:

PDF

References


WHO, Johns Hopkins Center for Communication Programs. Family planning: a global handbook for providers. 2022. Available from: http://www.fphandbook.org/

Kementerian Kesehatan RI. Pedoman pelayanan kontrasepsi dan keluarga berencana. Jakarta: Kementerian Kesehatan RI; 2021

Meiliza, Silaban TS, Farida T. Analisis faktor pemilihan KB suntik 3 bulan pada akseptor KB suntik. J Ilm PANNMED. 2022;17(1):115-123. DOI: 10.36911/pannmed.v17i1.1288

Widjayanti Y, Evi N, Masfi A, Rahmatika QT, Sunaryo EYAB, Ramadhan MP, et al. Effect of duration of use of depot medroxyprogesterone acetate and psychological stress on the female sexual function. Southeast Asian J Trop Med Public Health. 2023;54(Suppl 2):217-235.

Wulansari N, Sari E. Pengaruh konseling KB terhadap pengetahuan dan sikap pasangan usia subur dalam memilih KB yang tepat. Matern Child Health Care. 2023;5(1):831. DOI: 10.32883/mchc.v5i1.2405

Dwi Astuti N, Maineny A, Jesdika Longulo O, Sumiaty, Widyayanti A, Suryani S. The relationship between the duration of DMPA injection contraceptive use and menstrual disorders. Napande J Bidan. 2024;3(1):41-48. DOI: 10.33860/njb.v3i1.3539

Nurhayati N, S S, Hamang SH. Depo medroxyprogesterone acetate (DMPA): long-term effects on menstrual cycle disorders. Indones J Obstet Gynecol. 2023;11(2):93-98. DOI: 10.32771/inajog.v11i2.1884

Venesia Manek E, Prastyoningsih A, Bumi Pangesti C. Relationship between the duration of injectable contraceptive Depo Medroxy Progesterone Acetate (DMPA) with the occurrence of amenorrhea in family planning acceptors at the Pratama Delima Rahayu Clinic, Sragen. J Adv Nurs Health Sci. 2024;5(1):1-10. DOI: 10.34035/kn.v5i1.1284

Mukaromah N, Wardani NEK, Alfiah S, Sukesi. Hubungan penggunaan kontrasepsi suntik progestin dengan siklus menstruasi. Gema Bidan Indones. 2024;13(1):124-130. DOI: 10.36568/gebindo.v12i4.77

Efendi DF, Ferina F, Widaningsih N, Sariaty S. The relationship of side effects of Depo Medroxy Progesterone Acetate (DMPA) injections to continuation of contraceptive use. J Midwifery Reprod Health. 2025;2(2):1-8. DOI: 10.34035/jmrh.v2i2.1927

Lestaluhu IR. Hubungan gangguan haid, keputihan, dan penurunan libido pada akseptor KB suntik 3 bulan. SIMFISIS J Kebidanan Indones. 2023;3(1):568-574. DOI: 10.53801/sjki.v3i1.179

Harnani BD, Wahyuni S, Herawati Z, Wulandari E, Reflisiani D, Rahayu R, et al. Modul bahan ajar kesehatan reproduksi dan keluarga berencana. Vol. 1. 2021. 1-203 p.

Manurung S. Model pengambilan keputusan meningkatkan akseptor keluarga berencana metode kontrasepsi jangka panjang. Kesmas Natl Public Health J. 2013;7(11):483. DOI: 10.21109/kesmas.v7i11.360

Kemenkes Kesehatan RI. Modul pelatihan pelayanan kontrasepsi bagi dokter dan bidan di fasilitas pelayanan kesehatan. Jakarta: Kementerian Kesehatan RI; 2023. p. 37-64.

Widjayanti Y, Evi N, Masfi A, Ramadhan MP. Akseptor keluarga berencana: faktor yang memengaruhi pemilihan kontrasepsi Depo Medroxy Progesterone Acetate (DMPA). J IJPN. 2023;4(1):29-36. DOI: 10.30587/ijpn.v4i1.5687

Surbakti B, Purnamasari E, Agussamad I, Sihombing V, Sitompul L. Faktor-faktor yang memengaruhi pemilihan alat kontrasepsi. 2023:172-178. DOI: 10.33024/mj.v3i4.13101

Dwi IH, Sholeha H, Hasanah TN, Panca W, Evangelina IM, Magno A, et al. Literature review: association between DMPA injectable contraceptive use and menstrual cycle disorders in family planning acceptors. Proceedings of Conference on Health Universitas Ngudi Waluyo. 2026;3(1):260-266.

Budu E, Okyere J, Osei MD, Seidu AA, Ahinkorah BO. Determinants of contraceptive continuation among women in sub-Saharan Africa. BMC Womens Health. 2023;23(1):1-8. DOI: 10.1186/s12905-023-02578-8

Xavier D, Anne-Cécile P, Laurent G, Christine R, Camille LRAY, Thierry B, et al. Pelvic exam in gynecology and obstetrics: French guidelines for clinical practice. 2023. DOI: 10.1016/j.ejogrb.2023.10.007

Silvia, Jayatmi I, Rini AS. Hubungan gangguan pola menstruasi, nyeri kepala, dan tekanan darah terhadap efek samping KB suntik 3 bulan. J Ilm Kebidanan Indones. 2024;14(1):18-23. DOI: 10.33221/jiki.v14i02.2433

Fairuz F, Dewi H, Kusdiyah E. Pemeriksaan Pap Smear sebagai skrining lesi prekanker leher rahim. J Karya Abdi. 2021;5(3):639-641.DOI: 10.22437/jkam.v5i3.16681

FFiorentino MC, Villani FP, Di Cosmo M, Frontoni E, Moccia S. A review on deep-learning algorithms for fetal ultrasound-image analysis. Med Image Anal. 2023;83:102629. DOI: 10.1016/j.media.2022.102629




DOI: https://doi.org/10.33846/%25x

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN: 2621-8224 ----- Publisher: Alliance of Health Activists (AloHA) ----- Address: Jl. Ngurah Rai 18, Bangli, Bali, Indonesia